Asthma is the third-most common chronic disease in Canada, affecting nearly 3 million Canadians over the age of 12. It is also the leading cause of hospitalization, representing a significant cost to the healthcare system.

Although only 5–10% of people with asthma have what is called severe asthma, they account for a disproportionate share of the overall disease burden. Severe asthma is responsible for approximately 50% of all direct asthma-related costs, while also taking a significant toll of people’s quality of life.

The standard treatment relies on oral corticosteroids, but a growing body of research shows that biologic or targeted therapies may be highly effective in managing severe asthma.

A recent paper published in the Canadian Journal of Respiratory, Critical Care, and Sleep Medicine discusses the underutilization of biologic therapy in treating severe asthma and how these therapies can be adopted into regular clinical practice.

In “Targeted management of severe asthma: Developing a Canadian approach,” Dr. Kenneth R. Chapman writes: “Both Canadian and international research suggests that the adverse effects of oral corticosteroids in severe asthma are significant and costly but under-recognized. Our review of management of severe asthma in Canada highlights the need for increased recognition of the adverse effects of oral corticosteroids and more a

Awareness of the newer alternative therapies on the part of physicians, as well as access to specialized care for the population with severe asthma including patient education resources, and ongoing monitoring with a severe asthma registry.”

For more about targeted biologic therapies and the potential for treating severe asthma, read the full review here.

At Bridge Medical Communications, we are pleased to support these important publications. Our team is committed to building connections between health care practitioners and industry leaders through education, consultancy, practice assessment, and medical literature.

Click here to find out more about how Bridge Medical Communications’ customized solutions can help meet the complex needs of your business.